| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |